# Mark R. Middleton

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-r-middleton/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,014 |
| Field | Melanoma and MAPK Pathways |
| h-index | 79 |
| i10-index | 271 |
| Last Known Institution | Churchill Hospital |
| OpenAlex ID | https://openalex.org/A5051430596 |
| ORCID iD | https://orcid.org/0000-0003-0167-1685 |
| Works | 752 |

## Researcher papers

- [Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines](https://scholariq.org/papers/diagnosis-and-treatment-of-basal-cell-carcinoma-european-consensus-based/)
- [Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016](https://scholariq.org/papers/diagnosis-and-treatment-of-melanoma-european-consensus-based-interdisciplinary/)
- [Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-nivolumab-versus-ipilimumab-in-resected-stage-iiib-c-and-stage-iv/)
- [Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-invasive-squamous-cell-carcinoma-of-the-skin-european/)
- [Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-merkel-cell-carcinoma-european-consensus-based/)
- [European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment](https://scholariq.org/papers/european-interdisciplinary-guideline-on-invasive-squamous-cell-carcinoma-of-the/)
- [Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus](https://scholariq.org/papers/common-variants-at-the-mhc-locus-and-at-chromosome-16q24-1-predispose-to-barrett/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Churchill Hospital](https://scholariq.org/institutions/churchill-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.